{"filing":{"accession_number":"0001104659-26-076845","cik":"0001814114","ticker":"OBIO","company_name":"Orchestra BioMed Holdings, Inc.","form":"8-K","filing_date":"2026-06-23","report_date":null,"primary_document":"tm2618372d2_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1814114/000110465926076845/tm2618372d2_8k.htm"},"events":[{"id":13245,"run_id":11754,"accession_number":"0001104659-26-076845","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the results of Orchestra BioMed's 2026 Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for five proposals: election of three Class III directors (David P. Hochman, Darren R. Sherman, and Eric S. Fain), ratification of Ernst \u0026 Young LLP as independent auditor, approval of the 2026 Employee Stock Purchase Plan, advisory vote on named executive officer compensation, and advisory vote on compensation vote frequency. All proposals passed. This is a material governance event affecting investor understanding of board composition and corporate governance decisions.","company_name":"Orchestra BioMed Holdings, Inc.","ticker":"OBIO","filing_date":"2026-06-23","form":"8-K","submitted_at":null,"items":[{"id":10332,"accession_number":"0001104659-26-076845","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Orchestra BioMed's 2026 Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for five proposals: election of three Class III directors (David P. Hochman, Darren R. Sherman, and Eric S. Fain), ratification of Ernst \u0026 Young LLP as independent auditor, approval of the 2026 Employee Stock Purchase Plan, advisory vote on named executive officer compensation, and advisory vote on compensation vote frequency. All proposals passed. This is a material governance event affecting investor understanding of board composition and corporate governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:53:36.495002+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":10332,"accession_number":"0001104659-26-076845","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the results of Orchestra BioMed's 2026 Annual Meeting of Stockholders held on June 23, 2026. The filing presents voting results for five proposals: election of three Class III directors (David P. Hochman, Darren R. Sherman, and Eric S. Fain), ratification of Ernst \u0026 Young LLP as independent auditor, approval of the 2026 Employee Stock Purchase Plan, advisory vote on named executive officer compensation, and advisory vote on compensation vote frequency. All proposals passed. This is a material governance event affecting investor understanding of board composition and corporate governance decisions.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-23T20:53:36.495002+00:00","company_name":"Orchestra BioMed Holdings, Inc.","ticker":"OBIO","filing_date":"2026-06-23"}]}